| Disease Term | Human Homologs | Mouse Homologs | Mouse Models | Homology Source | |||
  | 17-beta hydroxysteroid dehydrogenase 3 deficiency | HSD17B3* | Hsd17b3* | 1 model | Alliance of Genome Resources | ||
| 46,XY sex reversal | DHH* | Dhh* | 1 model | Alliance of Genome Resources | |||
| adrenocorticotropic hormone deficiency | TBX19* | Tbx19* | 1 model | Alliance of Genome Resources | |||
| androgen insensitivity syndrome | AR* | Ar* | 8 models | Alliance of Genome Resources | |||
| autoimmune polyendocrine syndrome type 1 | AIRE* | Aire* | 9 models | Alliance of Genome Resources | |||
| Bamforth-Lazarus syndrome | FOXE1* | Foxe1* | 1 model | Alliance of Genome Resources | |||
| central precocious puberty 2 | MKRN3* | Mkrn3* | 1 model | Alliance of Genome Resources | |||
| congenital hypothyroidism | PAX8* | Pax8* | 3 models | Alliance of Genome Resources | |||
| congenital hypothyroidism | DUOX2* | Duox2* | 1 model | Alliance of Genome Resources | |||
| congenital hypothyroidism | TPO* | Tpo* | 1 model | Alliance of Genome Resources | |||
| corticosteroid-binding globulin deficiency | SERPINA6* | Serpina6* | 2 models | Alliance of Genome Resources | |||
| cortisone reductase deficiency 2 | HSD11B1* | Hsd11b1* | 1 model | Alliance of Genome Resources | |||
| cryptorchidism | INSL3* | Insl3* | 5 models | Alliance of Genome Resources | |||
| hyperparathyroidism | CASR* | Casr* | 6 models | Alliance of Genome Resources | |||
| hyperparathyroidism | CDC73* | Cdc73* | 3 models | Alliance of Genome Resources | |||
| hyperparathyroidism | MEN1* | Men1* | 1 model | Alliance of Genome Resources | |||
| hypogonadotropic hypogonadism 11 with or without anosmia | TACR3* | Tacr3* | 1 model | Alliance of Genome Resources | |||
| hypogonadotropic hypogonadism 12 with or without anosmia | GNRH1* | Gnrh1* | 1 model | Alliance of Genome Resources | |||
| hypogonadotropic hypogonadism 13 with or without anosmia | KISS1* | Kiss1* | 2 models | Alliance of Genome Resources | |||
| hypogonadotropic hypogonadism 7 with or without anosmia | GNRHR* | Gnrhr* | 1 model | Alliance of Genome Resources | |||
| hypogonadotropic hypogonadism 8 with or without anosmia | KISS1R* | Kiss1r* | 4 models | Alliance of Genome Resources | |||
| hypopituitarism | PROP1* | Prop1* | 2 models | Alliance of Genome Resources | |||
| isolated growth hormone deficiency type II | GH1*, CSH1, CSH2, CSHL1, GH2 | Gh* | 2 models | Alliance of Genome Resources | |||
| Kallmann syndrome | SOX10* | Sox10* | 1 model | Alliance of Genome Resources | |||
| Mahvash Disease | GCGR* | Gcgr* | 1 model | Alliance of Genome Resources | |||
| ovarian cancer | CTNNB1* | Ctnnb1* | 6 models | Alliance of Genome Resources | |||
| persistent Mullerian duct syndrome | AMHR2* | Amhr2* | 1 model | Alliance of Genome Resources | |||
| primary hyperaldosteronism | CLCN2* | Clcn2* | 1 model | Alliance of Genome Resources | |||
| primary ovarian insufficiency 12 | SYCE1* | Syce1* | 1 model | Alliance of Genome Resources | |||
| primary ovarian insufficiency 13 | MSH5* | Msh5* | 1 model | Alliance of Genome Resources | |||
| primary ovarian insufficiency 19 | HSF2BP* | Hsf2bp* | 1 model | Alliance of Genome Resources | |||
| primary pigmented nodular adrenocortical disease | PRKAR1A* | Prkar1a* | 1 model | Alliance of Genome Resources | |||
| thyroid gland papillary carcinoma | BRAF* | Braf* | 2 models | Alliance of Genome Resources | |||
| thyroid hormone resistance syndrome | THRB* | Thrb* | 10 models | Alliance of Genome Resources | |||
| type 1 diabetes mellitus | PTPRN2* | Ptprn2* | 1 model | Alliance of Genome Resources | |||
| type 1 diabetes mellitus | INS* | Ins2*, Ins1 | 6 models | Alliance of Genome Resources | |||
| type 1 diabetes mellitus | IL1R1* | Il1r1* | 1 model | Alliance of Genome Resources | |||
| type 1 diabetes mellitus | GAD2* | Gad2* | 1 model | Alliance of Genome Resources | |||
| type 1 diabetes mellitus | CD38* | Cd38* | 1 model | Alliance of Genome Resources | |||
| X-linked adrenal hypoplasia congenita | NR0B1* | Nr0b1* | 1 model | Alliance of Genome Resources | |||
| | 46 XX gonadal dysgenesis | FANCL | Fancl* | 1 model | Alliance of Genome Resources | ||
| adrenal gland disease | MRAP | Mrap* | 1 model | Alliance of Genome Resources | |||
| androgen insensitivity syndrome | FKBP4 | Fkbp4* | 2 models | Alliance of Genome Resources | |||
| annular pancreas | GDF1 | Gdf1* | 1 model | Alliance of Genome Resources | |||
| annular pancreas | IHH | Ihh* | 1 model | Alliance of Genome Resources | |||
| congenital hypothyroidism | TRHR | Trhr* | 1 model | Alliance of Genome Resources | |||
| congenital hypothyroidism | TSHR | Tshr* | 4 models | Alliance of Genome Resources | |||
| congenital hypothyroidism | SLC26A7 | Slc26a7* | 1 model | Alliance of Genome Resources | |||
| congenital hypothyroidism | TG | Tg* | 1 model | Alliance of Genome Resources | |||
| congenital hypothyroidism | FOXE1 | Foxe1* | 1 model | Alliance of Genome Resources | |||
| congenital hypothyroidism | RUNX2 | Runx2* | 1 model | Alliance of Genome Resources | |||
| dermoid cyst of ovary | FOXO3, FOXO3B | Foxo3* | 1 model | Alliance of Genome Resources | |||
| endocrine system disease | B4GALT1 | B4galt1* | 1 model | Alliance of Genome Resources | |||
| endocrine system disease | PCSK1 | Pcsk1* | 1 model | Alliance of Genome Resources | |||
| familial medullary thyroid carcinoma | PRLR | Prlr* | 1 model | Alliance of Genome Resources | |||
| growth hormone secreting pituitary adenoma | MEN1 | Men1* | 1 model | Alliance of Genome Resources | |||
| hyperandrogenism | Prl3c1* | 1 model | |||||
| hypogonadotropic hypogonadism | NR5A1 | Nr5a1* | 1 model | Alliance of Genome Resources | |||
| hypoparathyroidism | GCM2 | Gcm2* | 1 model | Alliance of Genome Resources | |||
| hypopituitarism | HESX1 | Hesx1* | 1 model | Alliance of Genome Resources | |||
| hypopituitarism | LHX3 | Lhx3* | 1 model | Alliance of Genome Resources | |||
| hypopituitarism | SMPD3 | Smpd3* | 1 model | Alliance of Genome Resources | |||
| isolated growth hormone deficiency type IA | GHRH | Ghrh* | 1 model | Alliance of Genome Resources | |||
| Kallmann syndrome | WDR11 | Wdr11* | 1 model | Alliance of Genome Resources | |||
| ovarian cancer | APC | Apc* | 2 models | Alliance of Genome Resources | |||
| ovarian disease | PATL2 | Patl2* | 1 model | Alliance of Genome Resources | |||
| ovarian hyperstimulation syndrome | NR1H3 | Nr1h3* | 1 model | Alliance of Genome Resources | |||
| pancreatic carcinoma | KRAS | Kras* | 13 models | Alliance of Genome Resources | |||
| pancreatic carcinoma | MYC | Myc*, Bmyc | 3 models | Alliance of Genome Resources | |||
| pancreatitis | CPA1 | Cpa1* | 1 model | Alliance of Genome Resources | |||
| pancreatitis | Prss3b* | 1 model | |||||
| pituitary-dependent Cushing's disease | SCG5 | Scg5* | 1 model | Alliance of Genome Resources | |||
| polycystic ovary syndrome | AKT2 | Akt2* | 1 model | Alliance of Genome Resources | |||
| primary hyperaldosteronism | NR3C1 | Nr3c1* | 1 model | Alliance of Genome Resources | |||
| primary hyperaldosteronism | DRD2 | Drd2* | 1 model | Alliance of Genome Resources | |||
| primary hyperaldosteronism | CRH | Crh* | 1 model | Alliance of Genome Resources | |||
| primary ovarian insufficiency | FANCF | Fancf* | 1 model | Alliance of Genome Resources | |||
| primary ovarian insufficiency | POLR3H | Polr3h* | 1 model | Alliance of Genome Resources | |||
| prolactinoma | MEN1 | Men1* | 1 model | Alliance of Genome Resources | |||
| thyroid gland follicular carcinoma | PRKAR1A | Prkar1a* | 2 models | Alliance of Genome Resources | |||
| thyroid gland follicular carcinoma | PTEN | Pten* | 3 models | Alliance of Genome Resources | |||
| thyroid gland follicular carcinoma | THRB | Thrb* | 2 models | Alliance of Genome Resources | |||
| thyroid hormone resistance syndrome | THRA | Thra* | 2 models | Alliance of Genome Resources | |||
| thyroid hormone resistance syndrome | NCOA1 | Ncoa1* | 1 model | Alliance of Genome Resources | |||
| type 1 diabetes mellitus | CDK4 | Cdk4* | 1 model | Alliance of Genome Resources | |||
| type 1 diabetes mellitus | E2F1 | E2f1* | 1 model | Alliance of Genome Resources | |||
| type 1 diabetes mellitus | FASLG | Fasl* | 3 models | Alliance of Genome Resources | |||
| type 1 diabetes mellitus | G6PC2 | G6pc2* | 1 model | Alliance of Genome Resources | |||
| type 1 diabetes mellitus | IFNG | Ifng* | 2 models | Alliance of Genome Resources | |||
| type 1 diabetes mellitus | IFNGR2 | Ifngr2* | 1 model | Alliance of Genome Resources | |||
| type 1 diabetes mellitus | IGHM | Ighm* | 5 models | Alliance of Genome Resources | |||
| type 1 diabetes mellitus | IL4 | Il4* | 2 models | Alliance of Genome Resources | |||
| type 1 diabetes mellitus | IRAK3 | Irak3* | 1 model | Alliance of Genome Resources | |||
| type 1 diabetes mellitus | MBD2 | Mbd2* | 1 model | Alliance of Genome Resources | |||
| type 1 diabetes mellitus | NOS2 | Nos2* | 5 models | Alliance of Genome Resources | |||
| type 1 diabetes mellitus | PDX1 | Pdx1* | 1 model | Alliance of Genome Resources | |||
| type 1 diabetes mellitus | PRF1 | Prf1* | 2 models | Alliance of Genome Resources | |||
| type 1 diabetes mellitus | SELL | Sell* | 4 models | Alliance of Genome Resources | |||
| type 1 diabetes mellitus | SENP1 | Senp1* | 1 model | Alliance of Genome Resources | |||
| type 1 diabetes mellitus | STAT4 | Stat4* | 4 models | Alliance of Genome Resources | |||
| type 1 diabetes mellitus | TNFSF4 | Tnfsf4* | 1 model | Alliance of Genome Resources | |||
| type 1 diabetes mellitus 2 | IGF2 | Igf2* | 3 models | Alliance of Genome Resources | |||
| type 1 diabetes mellitus 7 | NEUROD1 | Neurod1* | 1 model | Alliance of Genome Resources | |||
| | 46 XX gonadal dysgenesis | ZSWIM7* | Zswim7 | Alliance of Genome Resources | |||
| 46 XX gonadal dysgenesis | FSHR* | Fshr | Alliance of Genome Resources | ||||
| 46 XX gonadal dysgenesis | SPIDR* | Spidr | Alliance of Genome Resources | ||||
| 46,XX sex reversal 1 | SRY* | Sry | Alliance of Genome Resources | ||||
| 46,XX sex reversal 4 | NR5A1* | Nr5a1 | Alliance of Genome Resources | ||||
| 46,XX sex reversal 5 | NR2F2* | Nr2f2 | Alliance of Genome Resources | ||||
| 46,XY sex reversal | DHX37* | Dhx37 | Alliance of Genome Resources | ||||
| 46,XY sex reversal | SRY* | Sry | Alliance of Genome Resources | ||||
| 46,XY sex reversal 1 | SRY* | Sry | Alliance of Genome Resources | ||||
| 46,XY sex reversal 2 | NR0B1* | Nr0b1 | Alliance of Genome Resources | ||||
| 46,XY sex reversal 3 | NR5A1* | Nr5a1 | Alliance of Genome Resources | ||||
| 46,XY sex reversal 5 | CBX2* | Cbx2 | Alliance of Genome Resources | ||||
| 46,XY sex reversal 6 | MAP3K1* | Map3k1 | Alliance of Genome Resources | ||||
| 46,XY sex reversal 7 | DHH* | Dhh | Alliance of Genome Resources | ||||
| 46,XY sex reversal 8 | AKR1C2*, AKR1C4*, AKR1C1, AKR1C3 | Akr1c6, Akr1c12, Akr1c13, Akr1c14, Akr1c18, Akr1c19, Akr1c20, Akr1c21, Akr1cl | Alliance of Genome Resources | ||||
| 46,XY sex reversal 9 | ZFPM2* | Zfpm2 | Alliance of Genome Resources | ||||
| ACTH-independent macronodular adrenal hyperplasia 1 | GNAS* | Gnas | Alliance of Genome Resources | ||||
| ACTH-independent macronodular adrenal hyperplasia 2 | ARMC5* | Armc5 | Alliance of Genome Resources | ||||
| ACTH-secreting pituitary adenoma | USP8* | Usp8 | Alliance of Genome Resources | ||||
| acute necrotizing pancreatitis | IL1RN* | Il1rn | Alliance of Genome Resources | ||||
| acute pancreatitis | F7* | F7 | Alliance of Genome Resources | ||||
| acute pancreatitis | IL10* | Il10 | Alliance of Genome Resources | ||||
| Addison's disease | CIITA* | Ciita | Alliance of Genome Resources | ||||
| Addison's disease | CLEC16A* | Clec16a | Alliance of Genome Resources | ||||
| Addison's disease | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
| Addison's disease | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
| Addison's disease | PTPN22* | Ptpn22 | Alliance of Genome Resources | ||||
| adrenal carcinoma | PTN* | Ptn | Alliance of Genome Resources | ||||
| adrenal cortical adenoma | PRKACA* | Prkaca | Alliance of Genome Resources | ||||
| alcoholic pancreatitis | CFTR* | Cftr | Alliance of Genome Resources | ||||
| alcoholic pancreatitis | UGT1A7*, UGT1A8, UGT1A9, UGT1A10 | Ugt1a7c, Ugt1a8, Ugt1a9, Ugt1a10 | Alliance of Genome Resources | ||||
| autoimmune pancreatitis | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
| autoimmune polyendocrine syndrome | HLA-DQA1*, HLA-DQA2 | H2-Aa | Alliance of Genome Resources | ||||
| autoimmune polyendocrine syndrome | AIRE* | Aire | Alliance of Genome Resources | ||||
| autoimmune polyendocrine syndrome | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
| autoimmune polyendocrine syndrome | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
| autoimmune polyendocrine syndrome type 1 | GH1*, CSH1, CSH2, CSHL1, GH2 | Gh | Alliance of Genome Resources | ||||
| autoimmune polyendocrine syndrome type 1 | GHRH* | Ghrh | Alliance of Genome Resources | ||||
| autoimmune polyendocrine syndrome type 2 | HLA-DQA1*, HLA-DQA2 | H2-Aa | Alliance of Genome Resources | ||||
| autoimmune polyendocrine syndrome type 2 | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
| autoimmune polyendocrine syndrome type 2 | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
| autoimmune thyroiditis | PTPN22* | Ptpn22 | Alliance of Genome Resources | ||||
| autoimmune thyroiditis | TG* | Tg | Alliance of Genome Resources | ||||
| autoimmune thyroiditis | ZFAT* | Zfat | Alliance of Genome Resources | ||||
| autoimmune thyroiditis | BANK1* | Bank1 | Alliance of Genome Resources | ||||
| autoimmune thyroiditis | CTLA4* | Ctla4 | Alliance of Genome Resources | ||||
| autoimmune thyroiditis | HLA-DQA1*, HLA-DQA2 | H2-Aa | Alliance of Genome Resources | ||||
| autoimmune thyroiditis | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
| autoimmune thyroiditis | HLA-DRA* | H2-Ea | Alliance of Genome Resources | ||||
| autoimmune thyroiditis | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
| autoimmune thyroiditis | LRP2* | Lrp2 | Alliance of Genome Resources | ||||
| autoimmune thyroiditis | MBL2* | Mbl2 | Alliance of Genome Resources | ||||
| autoimmune thyroiditis | PSMB9* | Psmb9 | Alliance of Genome Resources | ||||
| central precocious puberty 1 | KISS1R* | Kiss1r | Alliance of Genome Resources | ||||
| congenital adrenal insufficiency | CYP11A1* | Cyp11a1 | Alliance of Genome Resources | ||||
| congenital hypothyroidism | SLC5A5* | Slc5a5 | Alliance of Genome Resources | ||||
| congenital nongoitrous hypothyroidism 2 | PAX8* | Pax8 | Alliance of Genome Resources | ||||
| congenital nongoitrous hypothyroidism 4 | TSHB* | Tshb | Alliance of Genome Resources | ||||
| congenital nongoitrous hypothyroidism 5 | NKX2-5* | Nkx2-5 | Alliance of Genome Resources | ||||
| congenital nongoitrous hypothyroidism 6 | THRA* | Thra | Alliance of Genome Resources | ||||
| congenital nongoitrous hypothyroidism 7 | TRHR* | Trhr | Alliance of Genome Resources | ||||
| congenital nongoitrous hypothyroidism 8 | TBL1X*, TBL1Y | Tbl1x | Alliance of Genome Resources | ||||
| congenital nongoitrous hypothyroidism 9 | IRS4* | Irs4 | Alliance of Genome Resources | ||||
| corticosterone methyloxidase deficiency 1 | CYP11B2*, CYP11B1 | Cyp11b1, Cyp11b2 | Alliance of Genome Resources | ||||
| cortisone reductase deficiency | HSD11B1* | Hsd11b1 | Alliance of Genome Resources | ||||
| cortisone reductase deficiency | H6PD* | H6pd | Alliance of Genome Resources | ||||
| cortisone reductase deficiency 1 | H6PD* | H6pd | Alliance of Genome Resources | ||||
| cryptorchidism | RXFP2* | Rxfp2 | 2 models | Alliance of Genome Resources | |||
| cryptorchidism | HOXD13* | Hoxd13 | Alliance of Genome Resources | ||||
| cryptorchidism | AR* | Ar | 1 model | Alliance of Genome Resources | |||
| disorder of sexual development | AMH* | Amh | Alliance of Genome Resources | ||||
| disorder of sexual development | HSD17B3* | Hsd17b3 | Alliance of Genome Resources | ||||
| dysgerminoma | KIT* | Kit | Alliance of Genome Resources | ||||
| dysgerminoma | FGFR2* | Fgfr2 | Alliance of Genome Resources | ||||
| dystransthyretinemic hyperthyroxinemia | TTR* | Ttr | Alliance of Genome Resources | ||||
| exocrine pancreatic insufficiency | CFTR* | Cftr | Alliance of Genome Resources | ||||
| familial glucocorticoid deficiency | NNT* | Nnt | Alliance of Genome Resources | ||||
| familial glucocorticoid deficiency | MRAP* | Mrap | Alliance of Genome Resources | ||||
| familial glucocorticoid deficiency | TXNRD2* | Txnrd2 | Alliance of Genome Resources | ||||
| familial isolated hypoparathyroidism | GCM2* | Gcm2 | Alliance of Genome Resources | ||||
| familial isolated hypoparathyroidism | PTH* | Pth | Alliance of Genome Resources | ||||
| familial male-limited precocious puberty | LHCGR* | Lhcgr | Alliance of Genome Resources | ||||
| familial medullary thyroid carcinoma | RET* | Ret | 2 "NOT" models | Alliance of Genome Resources | |||
| glucocorticoid deficiency 1 | MC2R* | Mc2r | Alliance of Genome Resources | ||||
| glucocorticoid-remediable aldosteronism | CYP11B1*, CYP11B2 | Cyp11b1, Cyp11b2 | Alliance of Genome Resources | ||||
| goiter | SLC26A4* | Slc26a4 | Alliance of Genome Resources | ||||
| goiter | TG* | Tg | Alliance of Genome Resources | ||||
| gonadal disease | LHCGR* | Lhcgr | Alliance of Genome Resources | ||||
| gonadal dysgenesis | TSPYL1*, TSPYL6 | Tspyl1 | Alliance of Genome Resources | ||||
| Graves' disease | ADRB2* | Adrb2 | Alliance of Genome Resources | ||||
| Graves' disease | BTNL2* | Btnl2 | Alliance of Genome Resources | ||||
| Graves' disease | C4A*, C4B*, C4B_2 | C4a, C4b | Alliance of Genome Resources | ||||
| Graves' disease | CD40* | Cd40 | Alliance of Genome Resources | ||||
| Graves' disease | CD40LG* | Cd40lg | Alliance of Genome Resources | ||||
| Graves' disease | CTLA4* | Ctla4 | Alliance of Genome Resources | ||||
| Graves' disease | CYP1A1* | Cyp1a1 | Alliance of Genome Resources | ||||
| Graves' disease | DNMT1* | Dnmt1 | Alliance of Genome Resources | ||||
| Graves' disease | ESR2* | Esr2 | Alliance of Genome Resources | ||||
| Graves' disease | FKBP1B* | Fkbp1b | Alliance of Genome Resources | ||||
| Graves' disease | GC* | Gc | Alliance of Genome Resources | ||||
| Graves' disease | GSTP1* | Gstp1, Gstp2, Gstp3, Gstp-ps | Alliance of Genome Resources | ||||
| Graves' disease | HLA-DQA1*, HLA-DQA2 | H2-Aa | Alliance of Genome Resources | ||||
| Graves' disease | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
| Graves' disease | HLA-B*, HLA-A, HLA-C, HLA-E, HLA-F, HLA-G, HLA-H | H2-D1, H2-K1, H2-L, H2-M1, H2-M2, H2-M3, H2-M5, H2-M9, H2-M10.1, H2-M10.2, H2-M10.3, H2-M10.4, H2-M10.5, H2-M10.6, H2-M11, H2-Q1, H2-Q2, H2-Q4, H2-Q6, H2-Q7, H2-Q8, H2-Q10, H2-T3, H2-T10, H2-T22, H2-T23 | Alliance of Genome Resources | ||||
| Graves' disease | HLA-DRB1*, HLA-DRB3*, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
| Graves' disease | ICAM1* | Icam1 | Alliance of Genome Resources | ||||
| Graves' disease | IFNG* | Ifng | Alliance of Genome Resources | ||||
| Graves' disease | IL1B* | Il1b | Alliance of Genome Resources | ||||
| Graves' disease | IL2* | Il2 | Alliance of Genome Resources | ||||
| Graves' disease | IL3* | Il3 | Alliance of Genome Resources | ||||
| Graves' disease | IL6* | Il6 | Alliance of Genome Resources | ||||
| Graves' disease | IL10* | Il10 | Alliance of Genome Resources | ||||
| Graves' disease | IL13* | Il13 | Alliance of Genome Resources | ||||
| Graves' disease | IL17A* | Il17a | Alliance of Genome Resources | ||||
| Graves' disease | IL23R* | Il23r | Alliance of Genome Resources | ||||
| Graves' disease | LTA* | Lta | Alliance of Genome Resources | ||||
| Graves' disease | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
| Graves' disease | OGG1* | Ogg1 | Alliance of Genome Resources | ||||
| Graves' disease | PTPN22* | Ptpn22 | Alliance of Genome Resources | ||||
| Graves' disease | SERPINE1* | Serpine1 | Alliance of Genome Resources | ||||
| Graves' disease | TG* | Tg | Alliance of Genome Resources | ||||
| Graves' disease | TNF* | Tnf | Alliance of Genome Resources | ||||
| Graves' disease | TP53* | Trp53 | Alliance of Genome Resources | ||||
| Graves' disease | TSHR* | Tshr | Alliance of Genome Resources | ||||
| Graves' disease | VDR* | Vdr | Alliance of Genome Resources | ||||
| Graves' disease | VEGFA* | Vegfa | Alliance of Genome Resources | ||||
| growth hormone secreting pituitary adenoma 2 | GPR101* | Gpr101 | Alliance of Genome Resources | ||||
| hyperandrogenism | IL6ST* | Il6st | Alliance of Genome Resources | ||||
| hyperinsulinism | MTTP* | Mttp | Alliance of Genome Resources | ||||
| hyperinsulinism | GCK* | Gck | Alliance of Genome Resources | ||||
| hyperinsulinism | GLUD1*, GLUD2 | Glud1 | Alliance of Genome Resources | ||||
| hyperinsulinism | IL6* | Il6 | Alliance of Genome Resources | ||||
| hyperinsulinism | INS* | Ins1, Ins2 | Alliance of Genome Resources | ||||
| hyperinsulinism | KCNJ11* | Kcnj11 | Alliance of Genome Resources | ||||
| hyperinsulinism | LTA* | Lta | Alliance of Genome Resources | ||||
| hyperinsulinism | CDKN1C* | Cdkn1c | Alliance of Genome Resources | ||||
| hyperinsulinism | AGT* | Agt | Alliance of Genome Resources | ||||
| hyperinsulinism | ABCC8* | Abcc8 | Alliance of Genome Resources | ||||
| hyperinsulinism | PTPRF* | Ptprf | Alliance of Genome Resources | ||||
| hyperinsulinism | PARL* | Parl | Alliance of Genome Resources | ||||
| hyperparathyroidism | GCM2* | Gcm2 | Alliance of Genome Resources | ||||
| hyperparathyroidism | TRPV6* | Trpv6 | Alliance of Genome Resources | ||||
| hyperthyroidism | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
| hyperthyroxinemia | ALB* | Alb | Alliance of Genome Resources | ||||
| hypogonadism | PROP1* | Prop1 | Alliance of Genome Resources | ||||
| hypogonadism | KISS1R* | Kiss1r | Alliance of Genome Resources | ||||
| hypogonadotropic hypogonadism | TCF12* | Tcf12 | Alliance of Genome Resources | ||||
| hypogonadotropic hypogonadism | NDNF* | Ndnf | Alliance of Genome Resources | ||||
| hypogonadotropic hypogonadism | NHLH2* | Nhlh2 | Alliance of Genome Resources | ||||
| hypogonadotropic hypogonadism 10 with or without anosmia | TAC3* | Tac2 | Alliance of Genome Resources | ||||
| hypogonadotropic hypogonadism 14 with or without anosmia | WDR11* | Wdr11 | Alliance of Genome Resources | ||||
| hypogonadotropic hypogonadism 15 with or without anosmia | HS6ST1* | Hs6st1 | Alliance of Genome Resources | ||||
| hypogonadotropic hypogonadism 16 with or without anosmia | SEMA3A* | Sema3a | Alliance of Genome Resources | ||||
| hypogonadotropic hypogonadism 17 with or without anosmia | SPRY4* | Spry4 | Alliance of Genome Resources | ||||
| hypogonadotropic hypogonadism 18 with or without anosmia | IL17RD* | Il17rd | Alliance of Genome Resources | ||||
| hypogonadotropic hypogonadism 19 with or without anosmia | DUSP6* | Dusp6 | Alliance of Genome Resources | ||||
| hypogonadotropic hypogonadism 1 with or without anosmia | ANOS1* | ||||||
| hypogonadotropic hypogonadism 20 with or without anosmia | FGF17* | Fgf17 | Alliance of Genome Resources | ||||
| hypogonadotropic hypogonadism 21 with or without anosmia | FLRT3* | Flrt3 | Alliance of Genome Resources | ||||
| hypogonadotropic hypogonadism 22 with or without anosmia | FEZF1* | Fezf1 | Alliance of Genome Resources | ||||
| hypogonadotropic hypogonadism 23 with or without anosmia | LHB*, CGB1, CGB2, CGB3, CGB5, CGB7, CGB8 | Lhb | Alliance of Genome Resources | ||||
| hypogonadotropic hypogonadism 24 without anosmia | FSHB* | Fshb | Alliance of Genome Resources | ||||
| hypogonadotropic hypogonadism 2 with or without anosmia | FGFR1* | Fgfr1 | Alliance of Genome Resources | ||||
| hypogonadotropic hypogonadism 3 with or without anosmia | PROKR2* | Prokr2 | Alliance of Genome Resources | ||||
| hypogonadotropic hypogonadism 4 with or without anosmia | PROK2* | Prok2 | Alliance of Genome Resources | ||||
| hypogonadotropic hypogonadism 5 with or without anosmia | CHD7* | Chd7 | Alliance of Genome Resources | ||||
| hypogonadotropic hypogonadism 6 with or without anosmia | FGF8* | Fgf8 | Alliance of Genome Resources | ||||
| hypogonadotropic hypogonadism 7 with or without anosmia | FGFR1* | Fgfr1 | Alliance of Genome Resources | ||||
| hypogonadotropic hypogonadism 7 with or without anosmia | NSMF* | Nsmf | Alliance of Genome Resources | ||||
| hypogonadotropic hypogonadism 9 with or without anosmia | NSMF* | Nsmf | Alliance of Genome Resources | ||||
| hypoparathyroidism | GATA3* | Gata3 | Alliance of Genome Resources | ||||
| hypoparathyroidism | TBX1* | Tbx1 | Alliance of Genome Resources | ||||
| hypoparathyroidism | TBCE* | Tbce | Alliance of Genome Resources | ||||
| hypopituitarism | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
| hypothyroidism | TSHB* | Tshb | Alliance of Genome Resources | ||||
| hypothyroidism | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | Alliance of Genome Resources | ||||
| hypothyroidism | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
| hypothyroidism | PTPN22* | Ptpn22 | Alliance of Genome Resources | ||||
| insulinoma | INS* | Ins1, Ins2 | Alliance of Genome Resources | ||||
| islet cell tumor | DAXX* | Daxx | Alliance of Genome Resources | ||||
| isolated growth hormone deficiency | GHR* | Ghr | Alliance of Genome Resources | ||||
| isolated growth hormone deficiency | GH1*, CSH1, CSH2, CSHL1, GH2 | Gh | Alliance of Genome Resources | ||||
| isolated growth hormone deficiency | GHRHR* | Ghrhr | Alliance of Genome Resources | ||||
| isolated growth hormone deficiency type IA | DNA2* | Dna2 | Alliance of Genome Resources | ||||
| isolated growth hormone deficiency type IA | GH1*, CSH1, CSH2, CSHL1, GH2 | Gh | Alliance of Genome Resources | ||||
| isolated growth hormone deficiency type IB | GH1*, CSH1, CSH2, CSHL1, GH2 | Gh | Alliance of Genome Resources | ||||
| isolated growth hormone deficiency type III | BTK* | Btk | Alliance of Genome Resources | ||||
| latent autoimmune diabetes in adults | CTLA4* | Ctla4 | Alliance of Genome Resources | ||||
| Leydig cell hypoplasia | LHCGR* | Lhcgr | Alliance of Genome Resources | ||||
| methemoglobinemia and ambiguous genitalia | CYB5A* | Cyb5a | Alliance of Genome Resources | ||||
| Mullerian aplasia and hyperandrogenism | WNT4* | Wnt4 | Alliance of Genome Resources | ||||
| multinodular goiter | DICER1* | Dicer1 | Alliance of Genome Resources | ||||
| nonautoimmune hyperthyroidism | TSHR* | Tshr | Alliance of Genome Resources | ||||
| opisthorchiasis | ACTR3* | Actr3 | Alliance of Genome Resources | ||||
| ovarian cancer | PRKCA* | Prkca | Alliance of Genome Resources | ||||
| ovarian cancer | CD59* | Cd59a, Cd59b | Alliance of Genome Resources | ||||
| ovarian cancer | CDH1* | Cdh1 | Alliance of Genome Resources | ||||
| ovarian cancer | CDH13* | Cdh13 | Alliance of Genome Resources | ||||
| ovarian cancer | CLDN4* | Cldn4, Cldn13 | Alliance of Genome Resources | ||||
| ovarian cancer | COMT* | Comt | Alliance of Genome Resources | ||||
| ovarian cancer | CYP19A1* | Cyp19a1 | Alliance of Genome Resources | ||||
| ovarian cancer | EEF1A2* | Eef1a2 | Alliance of Genome Resources | ||||
| ovarian cancer | ERBB2* | Erbb2 | Alliance of Genome Resources | ||||
| ovarian cancer | FANCA* | Fanca | Alliance of Genome Resources | ||||
| ovarian cancer | GHRH* | Ghrh | Alliance of Genome Resources | ||||
| ovarian cancer | GSTA1*, GSTA2, GSTA3, GSTA5 | Gsta1, Gsta2, Gsta3, Gsta5, Gsta13 | Alliance of Genome Resources | ||||
| ovarian cancer | GSTP1* | Gstp1, Gstp2, Gstp3, Gstp-ps | Alliance of Genome Resources | ||||
| ovarian cancer | HFE* | Hfe | Alliance of Genome Resources | ||||
| ovarian cancer | HMGA2* | Hmga2 | Alliance of Genome Resources | ||||
| ovarian cancer | ITGA8* | Itga8 | Alliance of Genome Resources | ||||
| ovarian cancer | JAK1* | Jak1 | Alliance of Genome Resources | ||||
| ovarian cancer | JUP* | Jup | Alliance of Genome Resources | ||||
| ovarian cancer | LEF1* | Lef1 | Alliance of Genome Resources | ||||
| ovarian cancer | MBL2* | Mbl2 | Alliance of Genome Resources | ||||
| ovarian cancer | MIR1271* | ||||||
| ovarian cancer | MMP1* | Mmp1a, Mmp1b | Alliance of Genome Resources | ||||
| ovarian cancer | MSLN* | Msln | Alliance of Genome Resources | ||||
| ovarian cancer | MUC16* | Muc16 | Alliance of Genome Resources | ||||
| ovarian cancer | MYO6* | Myo6 | Alliance of Genome Resources | ||||
| ovarian cancer | NBN* | Nbn | Alliance of Genome Resources | ||||
| ovarian cancer | NOD2* | Nod2 | Alliance of Genome Resources | ||||
| ovarian cancer | NOS3* | Nos3 | Alliance of Genome Resources | ||||
| ovarian cancer | OGG1* | Ogg1 | Alliance of Genome Resources | ||||
| ovarian cancer | OIP5-AS1* | ||||||
| ovarian cancer | OPCML* | Opcml | Alliance of Genome Resources | ||||
| ovarian cancer | PIK3CA* | Pik3ca | 1 model | Alliance of Genome Resources | |||
| ovarian cancer | PMS2*, PMS2P1, PMS2P2, PMS2P6 | Pms2 | Alliance of Genome Resources | ||||
| ovarian cancer | POT1* | Pot1a, Pot1b | Alliance of Genome Resources | ||||
| ovarian cancer | PRKN* | Prkn | Alliance of Genome Resources | ||||
| ovarian cancer | PTEN* | Pten | 8 models | Alliance of Genome Resources | |||
| ovarian cancer | RAD51* | Rad51 | Alliance of Genome Resources | ||||
| ovarian cancer | RASSF1* | Rassf1 | Alliance of Genome Resources | ||||
| ovarian cancer | RUNX3* | Runx3 | Alliance of Genome Resources | ||||
| ovarian cancer | SMAD2* | Smad2 | Alliance of Genome Resources | ||||
| ovarian cancer | SMAD4* | Smad4 | Alliance of Genome Resources | ||||
| ovarian cancer | SOD2* | Sod2 | Alliance of Genome Resources | ||||
| ovarian cancer | STAT3* | Stat3 | Alliance of Genome Resources | ||||
| ovarian cancer | TFRC* | Tfrc | Alliance of Genome Resources | ||||
| ovarian cancer | UGT1A1* | Ugt1a1 | Alliance of Genome Resources | ||||
| ovarian cancer | WRAP53* | Wrap53 | Alliance of Genome Resources | ||||
| ovarian cancer | AKT1* | Akt1 | Alliance of Genome Resources | ||||
| ovarian cancer | APEX1* | Apex1 | Alliance of Genome Resources | ||||
| ovarian cancer | APOB* | Apob | Alliance of Genome Resources | ||||
| ovarian cancer | AURKA* | Aurka | Alliance of Genome Resources | ||||
| ovarian cancer | BARD1* | Bard1 | Alliance of Genome Resources | ||||
| ovarian cancer | BRCA1* | Brca1 | 2 models | Alliance of Genome Resources | |||
| ovarian cancer | BRCA2* | Brca2 | 1 model | Alliance of Genome Resources | |||
| ovarian cancer | CAMK2N1* | Camk2n1 | Alliance of Genome Resources | ||||
| ovarian cancer | CCNG1* | Ccng1 | Alliance of Genome Resources | ||||
| ovarian carcinoma | SOCS1* | Socs1 | Alliance of Genome Resources | ||||
| ovarian carcinoma | CYTB* | mt-Cytb | Alliance of Genome Resources | ||||
| ovarian carcinoma | MMP13* | Mmp13 | Alliance of Genome Resources | ||||
| ovarian carcinoma | MIR23B* | Mir23b | Alliance of Genome Resources | ||||
| ovarian carcinoma | MAP2K6* | Map2k6 | Alliance of Genome Resources | ||||
| ovarian carcinoma | SOCS2* | Socs2 | Alliance of Genome Resources | ||||
| ovarian carcinoma | STK11* | Stk11 | Alliance of Genome Resources | ||||
| ovarian carcinoma | AKT2* | Akt2 | Alliance of Genome Resources | ||||
| ovarian carcinoma | L1CAM* | L1cam | Alliance of Genome Resources | ||||
| ovarian carcinoma | CCNG1* | Ccng1 | Alliance of Genome Resources | ||||
| ovarian carcinoma | CCND1* | Ccnd1 | Alliance of Genome Resources | ||||
| ovarian carcinoma | CASP6* | Casp6 | Alliance of Genome Resources | ||||
| ovarian carcinoma | CAMK2N1* | Camk2n1 | Alliance of Genome Resources | ||||
| ovarian carcinoma | CABIN1* | Cabin1 | Alliance of Genome Resources | ||||
| ovarian carcinoma | AMH* | Amh | Alliance of Genome Resources | ||||
| ovarian clear cell carcinoma | ARID1A* | Arid1a | Alliance of Genome Resources | ||||
| ovarian dysgenesis 1 | FSHR* | Fshr | Alliance of Genome Resources | ||||
| ovarian dysgenesis 2 | BMP15* | Bmp15 | Alliance of Genome Resources | ||||
| ovarian dysgenesis 3 | PSMC3IP* | Psmc3ip | Alliance of Genome Resources | ||||
| ovarian dysgenesis 4 | MCM9* | Mcm9 | Alliance of Genome Resources | ||||
| ovarian dysgenesis 5 | SOHLH1* | Sohlh1 | Alliance of Genome Resources | ||||
| ovarian dysgenesis 6 | NUP107* | Nup107 | Alliance of Genome Resources | ||||
| ovarian dysgenesis 7 | MRPS22* | Mrps22 | Alliance of Genome Resources | ||||
| ovarian dysgenesis 8 | ESR2* | Esr2 | Alliance of Genome Resources | ||||
| ovarian endometrial cancer | ARHGEF10L* | Arhgef10l | Alliance of Genome Resources | ||||
| ovarian hyperstimulation syndrome | SERPINF1* | Serpinf1 | Alliance of Genome Resources | ||||
| ovarian hyperstimulation syndrome | FSHR* | Fshr | Alliance of Genome Resources | ||||
| ovarian serous carcinoma | MAP2K4* | Map2k4 | Alliance of Genome Resources | ||||
| ovarian serous carcinoma | ARHGEF10L* | Arhgef10l | Alliance of Genome Resources | ||||
| ovary epithelial cancer | KIF1B* | Kif1b | Alliance of Genome Resources | ||||
| ovary epithelial cancer | TAB2* | Tab2 | Alliance of Genome Resources | ||||
| ovary epithelial cancer | DAXX* | Daxx | Alliance of Genome Resources | ||||
| ovary epithelial cancer | CCR3* | Ccr3 | Alliance of Genome Resources | ||||
| ovary epithelial cancer | AKAP6* | Akap6 | Alliance of Genome Resources | ||||
| ovary epithelial cancer | NME1* | Nme1 | Alliance of Genome Resources | ||||
| ovary epithelial cancer | H19* | ||||||
| ovary epithelial cancer | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
| ovary epithelial cancer | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
| ovary epithelial cancer | ERCC2* | Ercc2 | Alliance of Genome Resources | ||||
| ovary epithelial cancer | ERCC1* | Ercc1 | Alliance of Genome Resources | ||||
| ovary serous adenocarcinoma | TP53* | Trp53 | Alliance of Genome Resources | ||||
| pancreas disease | HNF1B* | Hnf1b | Alliance of Genome Resources | ||||
| pancreas disease | MSLN* | Msln | Alliance of Genome Resources | ||||
| pancreatic acinar cell adenocarcinoma | BRAF* | Braf | Alliance of Genome Resources | ||||
| pancreatic adenocarcinoma | JAK1* | Jak1 | Alliance of Genome Resources | ||||
| pancreatic adenocarcinoma | CDK4* | Cdk4 | Alliance of Genome Resources | ||||
| pancreatic adenocarcinoma | CDK6* | Cdk6 | Alliance of Genome Resources | ||||
| pancreatic adenocarcinoma | CDKN2A* | Cdkn2a | Alliance of Genome Resources | ||||
| pancreatic adenocarcinoma | CXCR4* | Cxcr4 | Alliance of Genome Resources | ||||
| pancreatic adenocarcinoma | E2F1* | E2f1 | Alliance of Genome Resources | ||||
| pancreatic adenocarcinoma | GSTT1* | Gstt1 | Alliance of Genome Resources | ||||
| pancreatic adenocarcinoma | MAP2K1* | Map2k1 | Alliance of Genome Resources | ||||
| pancreatic adenocarcinoma | MAPK9* | Mapk9 | Alliance of Genome Resources | ||||
| pancreatic adenocarcinoma | MAPK10* | Mapk10 | Alliance of Genome Resources | ||||
| pancreatic adenocarcinoma | RAC1* | Rac1 | Alliance of Genome Resources | ||||
| pancreatic adenocarcinoma | RAF1* | Raf1 | Alliance of Genome Resources | ||||
| pancreatic adenocarcinoma | RALB* | Ralb | Alliance of Genome Resources | ||||
| pancreatic adenocarcinoma | RALBP1* | Ralbp1 | Alliance of Genome Resources | ||||
| pancreatic adenocarcinoma | SMAD7* | Smad7 | Alliance of Genome Resources | ||||
| pancreatic adenosquamous carcinoma | TGFB2* | Tgfb2 | Alliance of Genome Resources | ||||
| pancreatic agenesis | PTF1A* | Ptf1a | Alliance of Genome Resources | ||||
| pancreatic agenesis | PDX1* | Pdx1 | Alliance of Genome Resources | ||||
| pancreatic cancer | PALLD* | Palld | Alliance of Genome Resources | ||||
| pancreatic cancer | PDGFRA* | Pdgfra | Alliance of Genome Resources | ||||
| pancreatic cancer | NCAM1* | Ncam1 | Alliance of Genome Resources | ||||
| pancreatic cancer | OGG1* | Ogg1 | Alliance of Genome Resources | ||||
| pancreatic cancer | PALB2* | Palb2 | Alliance of Genome Resources | ||||
| pancreatic cancer | BRAF* | Braf | Alliance of Genome Resources | ||||
| pancreatic cancer | BRCA1* | Brca1 | Alliance of Genome Resources | ||||
| pancreatic cancer | BRCA2* | Brca2 | Alliance of Genome Resources | ||||
| pancreatic cancer | CAPN10* | Capn10 | Alliance of Genome Resources | ||||
| pancreatic cancer | CASP8* | Casp8 | Alliance of Genome Resources | ||||
| pancreatic cancer | CASP9* | Casp9 | Alliance of Genome Resources | ||||
| pancreatic cancer | CCKBR* | Cckbr | Alliance of Genome Resources | ||||
| pancreatic cancer | CCND1* | Ccnd1 | Alliance of Genome Resources | ||||
| pancreatic cancer | CCNG1* | Ccng1 | Alliance of Genome Resources | ||||
| pancreatic cancer | CDKN2A* | Cdkn2a | Alliance of Genome Resources | ||||
| pancreatic cancer | CFTR* | Cftr | Alliance of Genome Resources | ||||
| pancreatic cancer | CHEK1* | Chek1 | Alliance of Genome Resources | ||||
| pancreatic cancer | CLDN4* | Cldn4, Cldn13 | Alliance of Genome Resources | ||||
| pancreatic cancer | CYCS* | Cycs | Alliance of Genome Resources | ||||
| pancreatic cancer | CYP17A1* | Cyp17a1 | Alliance of Genome Resources | ||||
| pancreatic cancer | DPYD* | Dpyd | Alliance of Genome Resources | ||||
| pancreatic cancer | EGFR* | Egfr | Alliance of Genome Resources | ||||
| pancreatic cancer | EPHA3* | Epha3 | Alliance of Genome Resources | ||||
| pancreatic cancer | ERCC1* | Ercc1 | Alliance of Genome Resources | ||||
| pancreatic cancer | ERCC2* | Ercc2 | Alliance of Genome Resources | ||||
| pancreatic cancer | ERCC4* | Ercc4 | Alliance of Genome Resources | ||||
| pancreatic cancer | FANCA* | Fanca | Alliance of Genome Resources | ||||
| pancreatic cancer | FANCC* | Fancc | Alliance of Genome Resources | ||||
| pancreatic cancer | FANCG* | Fancg | Alliance of Genome Resources | ||||
| pancreatic cancer | FASLG* | Fasl | Alliance of Genome Resources | ||||
| pancreatic cancer | FGF2* | Fgf2 | Alliance of Genome Resources | ||||
| pancreatic cancer | GSTP1* | Gstp1, Gstp2, Gstp3, Gstp-ps | Alliance of Genome Resources | ||||
| pancreatic cancer | HS3ST2* | Hs3st2 | Alliance of Genome Resources | ||||
| pancreatic cancer | HSPB1* | Hspb1 | Alliance of Genome Resources | ||||
| pancreatic cancer | IGF1* | Igf1 | Alliance of Genome Resources | ||||
| pancreatic cancer | IGF1R* | Igf1r | Alliance of Genome Resources | ||||
| pancreatic cancer | IL1B* | Il1b | Alliance of Genome Resources | ||||
| pancreatic cancer | IL2* | Il2 | Alliance of Genome Resources | ||||
| pancreatic cancer | IL4* | Il4 | Alliance of Genome Resources | ||||
| pancreatic cancer | IL10* | Il10 | Alliance of Genome Resources | ||||
| pancreatic cancer | IL13* | Il13 | Alliance of Genome Resources | ||||
| pancreatic cancer | IL13RA2* | Il13ra2 | Alliance of Genome Resources | ||||
| pancreatic cancer | ILK* | Ilk | Alliance of Genome Resources | ||||
| pancreatic cancer | INS* | Ins1, Ins2 | Alliance of Genome Resources | ||||
| pancreatic cancer | ITGA4* | Itga4 | Alliance of Genome Resources | ||||
| pancreatic cancer | ITGA9* | Itga9 | Alliance of Genome Resources | ||||
| pancreatic cancer | ITGA11* | Itga11 | Alliance of Genome Resources | ||||
| pancreatic cancer | KDR* | Kdr | Alliance of Genome Resources | ||||
| pancreatic cancer | KRAS* | Kras | Alliance of Genome Resources | ||||
| pancreatic cancer | L1CAM* | L1cam | Alliance of Genome Resources | ||||
| pancreatic cancer | LIG3* | Lig3 | Alliance of Genome Resources | ||||
| pancreatic cancer | LIG4* | Lig4 | Alliance of Genome Resources | ||||
| pancreatic cancer | LUM* | Lum | Alliance of Genome Resources | ||||
| pancreatic cancer | MANF* | Manf | Alliance of Genome Resources | ||||
| pancreatic cancer | MAP2K4* | Map2k4 | Alliance of Genome Resources | ||||
| pancreatic cancer | MEN1* | Men1 | Alliance of Genome Resources | ||||
| pancreatic cancer | MKI67* | Mki67 | Alliance of Genome Resources | ||||
| pancreatic cancer | MPO* | Mpo | Alliance of Genome Resources | ||||
| pancreatic cancer | MSLN* | Msln | Alliance of Genome Resources | ||||
| pancreatic cancer | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
| pancreatic cancer | MTR* | Mtr | Alliance of Genome Resources | ||||
| pancreatic cancer | MTRR* | Mtrr | Alliance of Genome Resources | ||||
| pancreatic cancer | MUC1* | Muc1 | Alliance of Genome Resources | ||||
| pancreatic cancer | MUC4* | Muc4 | Alliance of Genome Resources | ||||
| pancreatic cancer | NAP1L1* | Nap1l1 | Alliance of Genome Resources | ||||
| pancreatic cancer | NAT1*, NAT2* | Nat1, Nat2, Nat3 | Alliance of Genome Resources | ||||
| pancreatic cancer | NUF2* | Nuf2 | Alliance of Genome Resources | ||||
| pancreatic cancer | XRCC3* | Xrcc3 | Alliance of Genome Resources | ||||
| pancreatic cancer | XRCC2* | Xrcc2 | Alliance of Genome Resources | ||||
| pancreatic cancer | XRCC1* | Xrcc1 | Alliance of Genome Resources | ||||
| pancreatic cancer | XPC* | Xpc | Alliance of Genome Resources | ||||
| pancreatic cancer | WNT9A* | Wnt9a | Alliance of Genome Resources | ||||
| pancreatic cancer | VHL*, VHLL | Vhl | Alliance of Genome Resources | ||||
| pancreatic cancer | UGT1A7*, UGT1A8, UGT1A9, UGT1A10 | Ugt1a7c, Ugt1a8, Ugt1a9, Ugt1a10 | Alliance of Genome Resources | ||||
| pancreatic cancer | TYMP* | Tymp | Alliance of Genome Resources | ||||
| pancreatic cancer | TP53* | Trp53 | Alliance of Genome Resources | ||||
| pancreatic cancer | THBS1* | Thbs1 | Alliance of Genome Resources | ||||
| pancreatic cancer | TGFBR2* | Tgfbr2 | Alliance of Genome Resources | ||||
| pancreatic cancer | TCF7L2* | Tcf7l2 | Alliance of Genome Resources | ||||
| pancreatic cancer | STK11* | Stk11 | Alliance of Genome Resources | ||||
| pancreatic cancer | SPP1* | Spp1 | Alliance of Genome Resources | ||||
| pancreatic cancer | SOD2* | Sod2 | Alliance of Genome Resources | ||||
| pancreatic cancer | SNW1* | Snw1 | Alliance of Genome Resources | ||||
| pancreatic cancer | SMO* | Smo | Alliance of Genome Resources | ||||
| pancreatic cancer | SMAD4* | Smad4 | Alliance of Genome Resources | ||||
| pancreatic cancer | SMAD3* | Smad3 | Alliance of Genome Resources | ||||
| pancreatic cancer | SEL1L* | Sel1l | Alliance of Genome Resources | ||||
| pancreatic cancer | RXRA* | Rxra | Alliance of Genome Resources | ||||
| pancreatic cancer | RUNX3* | Runx3 | Alliance of Genome Resources | ||||
| pancreatic cancer | RRM2* | Rrm2 | Alliance of Genome Resources | ||||
| pancreatic cancer | RECQL* | Recql | Alliance of Genome Resources | ||||
| pancreatic cancer | RAD54L* | Rad54l | Alliance of Genome Resources | ||||
| pancreatic cancer | RABL3* | Rabl3 | Alliance of Genome Resources | ||||
| pancreatic cancer | PTGS2* | Ptgs2 | Alliance of Genome Resources | ||||
| pancreatic cancer | PPARG* | Pparg | Alliance of Genome Resources | ||||
| pancreatic cancer | POLB* | Polb | Alliance of Genome Resources | ||||
| pancreatic cancer | ABO* | Abo | Alliance of Genome Resources | ||||
| pancreatic cancer | ACVR1B* | Acvr1b | Alliance of Genome Resources | ||||
| pancreatic cancer | ADH1C*, ADH1A, ADH1B | Adh1 | Alliance of Genome Resources | ||||
| pancreatic cancer | ADM* | Adm | Alliance of Genome Resources | ||||
| pancreatic cancer | AKT1* | Akt1 | Alliance of Genome Resources | ||||
| pancreatic cancer | ALDH2* | Aldh2 | Alliance of Genome Resources | ||||
| pancreatic cancer | ALOX5* | Alox5 | Alliance of Genome Resources | ||||
| pancreatic cancer | ANXA1* | Anxa1 | Alliance of Genome Resources | ||||
| pancreatic cancer | APC* | Apc | Alliance of Genome Resources | ||||
| pancreatic cancer | ARPC1A* | Arpc1a | Alliance of Genome Resources | ||||
| pancreatic cancer | ATM* | Atm | Alliance of Genome Resources | ||||
| pancreatic cancer | ATR* | Atr | Alliance of Genome Resources | ||||
| pancreatic cancer | BAD* | Bad | Alliance of Genome Resources | ||||
| pancreatic cancer | BCL2L1* | Bcl2l1 | Alliance of Genome Resources | ||||
| pancreatic cancer | BID* | Bid | Alliance of Genome Resources | ||||
| pancreatic carcinoma | KDR* | Kdr | Alliance of Genome Resources | ||||
| pancreatic carcinoma | CDKN2A* | Cdkn2a | 1 model | Alliance of Genome Resources | |||
| pancreatic ductal adenocarcinoma | MIR494* | Mir494 | Alliance of Genome Resources | ||||
| pancreatic ductal adenocarcinoma | GOT1* | Got1 | Alliance of Genome Resources | ||||
| pancreatic ductal adenocarcinoma | E2F1* | E2f1 | Alliance of Genome Resources | ||||
| pancreatic ductal adenocarcinoma | CCND1* | Ccnd1 | Alliance of Genome Resources | ||||
| pancreatic ductal adenocarcinoma | CALR* | Calr | Alliance of Genome Resources | ||||
| pancreatic ductal adenocarcinoma | TGFBR1* | Tgfbr1 | Alliance of Genome Resources | ||||
| pancreatic ductal adenocarcinoma | PIK3R2* | Pik3r2 | Alliance of Genome Resources | ||||
| pancreatic ductal carcinoma | MEN1* | Men1 | Alliance of Genome Resources | ||||
| pancreatic ductal carcinoma | SMO* | Smo | Alliance of Genome Resources | ||||
| pancreatic ductal carcinoma | MSLN* | Msln | Alliance of Genome Resources | ||||
| pancreatic ductal carcinoma | IL4* | Il4 | Alliance of Genome Resources | ||||
| pancreatic ductal carcinoma | MAPK3* | Mapk3 | Alliance of Genome Resources | ||||
| pancreatic ductal carcinoma | CD40* | Cd40 | Alliance of Genome Resources | ||||
| pancreatic ductal carcinoma | CDK6* | Cdk6 | Alliance of Genome Resources | ||||
| pancreatic ductal carcinoma | HEATR1* | Heatr1 | Alliance of Genome Resources | ||||
| pancreatic ductal carcinoma | GSTP1* | Gstp1, Gstp2, Gstp3, Gstp-ps | Alliance of Genome Resources | ||||
| pancreatic ductal carcinoma | PMS1* | Pms1 | Alliance of Genome Resources | ||||
| pancreatic ductal carcinoma | MGMT* | Mgmt | Alliance of Genome Resources | ||||
| pancreatic ductal carcinoma | FASLG* | Fasl | Alliance of Genome Resources | ||||
| pancreatic ductal carcinoma | VHL*, VHLL | Vhl | Alliance of Genome Resources | ||||
| pancreatic ductal carcinoma | THBS1* | Thbs1 | Alliance of Genome Resources | ||||
| pancreatic ductal carcinoma | MUC1* | Muc1 | Alliance of Genome Resources | ||||
| pancreatic ductal carcinoma | MDM2* | Mdm2 | Alliance of Genome Resources | ||||
| pancreatic endocrine carcinoma | PGF* | Pgf | Alliance of Genome Resources | ||||
| pancreatic endocrine carcinoma | DAXX* | Daxx | Alliance of Genome Resources | ||||
| pancreatic endocrine carcinoma | MGMT* | Mgmt | Alliance of Genome Resources | ||||
| pancreatic intraductal papillary-mucinous neoplasm | AKT1* | Akt1 | Alliance of Genome Resources | ||||
| pancreatic intraductal papillary-mucinous neoplasm | TP53* | Trp53 | Alliance of Genome Resources | ||||
| pancreatic mucinous cystadenoma | KRAS* | Kras | Alliance of Genome Resources | ||||
| pancreatitis | CCL5* | Ccl5 | Alliance of Genome Resources | ||||
| pancreatitis | CCL2*, CCL13 | Ccl2, Ccl12 | Alliance of Genome Resources | ||||
| pancreatitis | PRSS1*, PRSS2, PRSS3, PRSS3P2 | Prss1, Prss1l, Prss2, Prss3, Prss3l, Try4, Try5, Try10 | Alliance of Genome Resources | ||||
| pancreatitis | SERPING1* | Serping1 | Alliance of Genome Resources | ||||
| pancreatitis | SPINK1* | Spink1 | Alliance of Genome Resources | ||||
| panhypopituitarism | ROBO1* | Robo1 | Alliance of Genome Resources | ||||
| panhypopituitarism | LHX3* | Lhx3 | Alliance of Genome Resources | ||||
| panhypopituitarism | LHX4* | Lhx4 | Alliance of Genome Resources | ||||
| panhypopituitarism | OTX2* | Otx2 | Alliance of Genome Resources | ||||
| panhypopituitarism | POU1F1* | Pou1f1 | Alliance of Genome Resources | ||||
| panhypopituitarism | PROP1* | Prop1 | Alliance of Genome Resources | ||||
| panhypopituitarism | RNPC3* | Rnpc3 | Alliance of Genome Resources | ||||
| parathyroid carcinoma | CDC73* | Cdc73 | Alliance of Genome Resources | ||||
| partial androgen insensitivity syndrome | AR* | Ar | Alliance of Genome Resources | ||||
| persistent Mullerian duct syndrome | AMH* | Amh | Alliance of Genome Resources | ||||
| pituitary adenoma 1 | AIP* | Aip | Alliance of Genome Resources | ||||
| pituitary adenoma 3 | GNAS* | Gnas | Alliance of Genome Resources | ||||
| pituitary adenoma 5 | CDH23* | Cdh23 | Alliance of Genome Resources | ||||
| pituitary gland disease | POU1F1* | Pou1f1 | Alliance of Genome Resources | ||||
| polycystic ovary syndrome | VDR* | Vdr | Alliance of Genome Resources | ||||
| polycystic ovary syndrome | FST* | Fst | Alliance of Genome Resources | ||||
| polycystic ovary syndrome | CAPN10* | Capn10 | Alliance of Genome Resources | ||||
| polycystic ovary syndrome | CYP1A1* | Cyp1a1 | Alliance of Genome Resources | ||||
| polycystic ovary syndrome | CYP19A1* | Cyp19a1 | Alliance of Genome Resources | ||||
| premature menopause | POLG* | Polg | Alliance of Genome Resources | ||||
| primary hyperaldosteronism | CACNA1H* | Cacna1h | Alliance of Genome Resources | ||||
| primary hyperaldosteronism | CYP11B1*, CYP11B2* | Cyp11b1, Cyp11b2 | Alliance of Genome Resources | ||||
| primary hyperaldosteronism | KCNJ5* | Kcnj5 | Alliance of Genome Resources | ||||
| primary hyperparathyroidism | VDR* | Vdr | Alliance of Genome Resources | ||||
| primary hyperparathyroidism | MIR30E* | Mir30e | Alliance of Genome Resources | ||||
| primary ovarian insufficiency | XPO5* | Xpo5 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency | TP63* | Trp63 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency | POLG* | Polg | Alliance of Genome Resources | ||||
| primary ovarian insufficiency | MSH4* | Msh4 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency | KASH5* | Kash5 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency | FANCA* | Fanca | Alliance of Genome Resources | ||||
| primary ovarian insufficiency | DIAPH2* | Diaph2 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency | BMP15* | Bmp15 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency | BBS9* | Bbs9 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 1 | FMR1* | Fmr1 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 10 | MCM8* | Mcm8 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 11 | ERCC6* | Ercc6 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 14 | GDF9* | Gdf9 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 15 | FANCM* | Fancm | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 16 | BNC1* | Bnc1 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 17 | XRCC2* | Xrcc2 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 18 | C14orf39* | 4930447C04Rik | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 2A | DIAPH2* | Diaph2 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 2B | POF1B* | Pof1b | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 3 | FOXL2* | Foxl2 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 5 | NOBOX* | Nobox | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 6 | FIGLA* | Figla | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 7 | NR5A1* | Nr5a1 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 8 | STAG3* | Stag3 | Alliance of Genome Resources | ||||
| primary ovarian insufficiency 9 | HFM1* | Hfm1 | Alliance of Genome Resources | ||||
| primary pigmented nodular adrenocortical disease | PDE8B* | Pde8b | Alliance of Genome Resources | ||||
| primary pigmented nodular adrenocortical disease | PRKACA* | Prkaca | Alliance of Genome Resources | ||||
| primary pigmented nodular adrenocortical disease | PDE11A* | Pde11a | Alliance of Genome Resources | ||||
| secondary hyperparathyroidism | CASR* | Casr | Alliance of Genome Resources | ||||
| secondary hyperparathyroidism | PTH* | Pth | Alliance of Genome Resources | ||||
| selective pituitary thyroid hormone resistance | THRB* | Thrb | Alliance of Genome Resources | ||||
| testicular cancer | GSTP1* | Gstp1, Gstp2, Gstp3, Gstp-ps | Alliance of Genome Resources | ||||
| testicular lymphoma | MYD88* | Myd88 | Alliance of Genome Resources | ||||
| thyroid dyshormonogenesis 1 | SLC5A5* | Slc5a5 | Alliance of Genome Resources | ||||
| thyroid dyshormonogenesis 2A | TPO* | Tpo | Alliance of Genome Resources | ||||
| thyroid dyshormonogenesis 3 | TG* | Tg | Alliance of Genome Resources | ||||
| thyroid dyshormonogenesis 4 | IYD* | Iyd | Alliance of Genome Resources | ||||
| thyroid dyshormonogenesis 5 | DUOXA2* | Duoxa2 | Alliance of Genome Resources | ||||
| thyroid dyshormonogenesis 6 | DUOX2* | Duox2 | Alliance of Genome Resources | ||||
| thyroid gland carcinoma | ATP6V0C* | Atp6v0c | Alliance of Genome Resources | ||||
| thyroid gland disease | DIO1* | Dio1 | Alliance of Genome Resources | ||||
| thyroid gland disease | TRU-TCA1-1* | ||||||
| thyroid gland disease | SECISBP2* | Secisbp2 | Alliance of Genome Resources | ||||
| thyroid gland Hurthle cell carcinoma | NDUFA13* | Ndufa13 | Alliance of Genome Resources | ||||
| thyroid gland papillary carcinoma | KMT2D* | Kmt2d | Alliance of Genome Resources | ||||
| thyroid gland papillary carcinoma | NRAS* | Nras | Alliance of Genome Resources | ||||
| thyroid gland papillary carcinoma | NKX2-1* | Nkx2-1 | Alliance of Genome Resources | ||||
| thyroid gland papillary carcinoma | MINPP1* | Minpp1 | Alliance of Genome Resources | ||||
| thyroid gland papillary carcinoma | XRCC1* | Xrcc1 | Alliance of Genome Resources | ||||
| thyroid gland papillary carcinoma | WDR3* | Wdr3 | Alliance of Genome Resources | ||||
| thyroid gland papillary carcinoma | ATM* | Atm | Alliance of Genome Resources | ||||
| thyroid gland papillary carcinoma | FOXE1* | Foxe1 | Alliance of Genome Resources | ||||
| thyroid gland papillary carcinoma | HRAS* | Hras | Alliance of Genome Resources | ||||
| thyroid gland papillary carcinoma | TP53* | Trp53 | Alliance of Genome Resources | ||||
| thyroid gland papillary carcinoma | SRGAP1* | Srgap1 | Alliance of Genome Resources | ||||
| thyroid gland papillary carcinoma | HABP2* | Habp2 | Alliance of Genome Resources | ||||
| Turner syndrome | IGFBP3* | Igfbp3 | Alliance of Genome Resources | ||||
| Turner syndrome | VDR* | Vdr | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | TF* | Trf | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | XYLT1* | Xylt1 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | TLR2* | Tlr2 | 1 "NOT" model | Alliance of Genome Resources | |||
| type 1 diabetes mellitus | TBP* | Tbp | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | TAP2* | Tap2 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | TAP1* | Tap1 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | SREBF2* | Srebf2 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | SOD2* | Sod2 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | SOD1* | Sod1 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | SLC11A1* | Slc11a1 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | SH2B3* | Sh2b3 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | REG1A*, REG1B | Reg1, Reg2 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | RAN* | Ran | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | PTPRN* | Ptprn | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | PTPN22* | Ptpn22 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | PTH* | Pth | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | PRRC2A* | Prrc2a | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | PAX4* | Pax4 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | NOTCH4* | Notch4 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | NEUROD1* | Neurod1 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | MTHFR* | Mthfr | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | MIR155* | Mir155 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | MIR146A* | Mir146 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | LTA* | Lta | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | ITPR3* | Itpr3 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | ISL1* | Isl1 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | IL15* | Il15 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | IL6* | Il6 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | IL2RA* | Il2ra | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | IL2* | Il2 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | IL1RN* | Il1rn | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | IL1B* | Il1b | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | IL1A* | Il1a | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | IGFBP3* | Igfbp3 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | IGF2R* | Igf2r | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | IGF1* | Igf1 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | ICAM1* | Icam1 | 1 "NOT" model | Alliance of Genome Resources | |||
| type 1 diabetes mellitus | ICA1* | Ica1 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | IAPP* | Iapp | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | HSD11B2* | Hsd11b2 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | HNF1A* | Hnf1a | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | HLA-DPB1* | ||||||
| type 1 diabetes mellitus | HLA-DPA1* | ||||||
| type 1 diabetes mellitus | HLA-DRB1*, HLA-DRB3, HLA-DRB4, HLA-DRB5 | H2-Eb1, H2-Eb2 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | HLA-DQB1*, HLA-DQB2 | H2-Ab1 | 3 models | Alliance of Genome Resources | |||
| type 1 diabetes mellitus | HLA-DQA1*, HLA-DQA2 | H2-Aa | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | GSTM1*, GSTM5 | Gstm1, Gstm2, Gstm3, Gstm6 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | GH1*, CSH1, CSH2, CSHL1, GH2 | Gh | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | GC* | Gc | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | FOXP3* | Foxp3 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | F7* | F7 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | ETS1* | Ets1 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | EIF2AK3* | Eif2ak3 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | DDX39B* | Ddx39b | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | CYP27B1* | Cyp27b1 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | CYP2R1* | Cyp2r1 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | CXCL12* | Cxcl12 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | CTLA4* | Ctla4 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | CLEC16A* | Clec16a | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | CFB* | Cfb | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | CEL* | Cel | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | CD86* | Cd86 | 1 model | Alliance of Genome Resources | |||
| type 1 diabetes mellitus | CD80* | Cd80 | 2 models | Alliance of Genome Resources | |||
| type 1 diabetes mellitus | CD28* | Cd28 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | CCR2* | Ccr2 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | CCL5* | Ccl5 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | CBLB* | Cblb | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | BTC* | Btc | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | BCHE* | Bche | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | BANK1* | Bank1 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | APOM* | Apom | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | APOC3* | Apoc3 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | ALDH2* | Aldh2 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | AIF1* | Aif1 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | AGER* | Ager | 1 model | Alliance of Genome Resources | |||
| type 1 diabetes mellitus | ACP1* | Acp1 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | ACE* | Ace | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | TLR3* | Tlr3 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | TNF* | Tnf | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus | WFS1* | Wfs1 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus 10 | IL2RA* | Il2ra | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus 12 | CTLA4* | Ctla4 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus 2 | INS* | Ins1, Ins2 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus 20 | HNF1A* | Hnf1a | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus 22 | CCR5* | Ccr5 | Alliance of Genome Resources | ||||
| type 1 diabetes mellitus 5 | SUMO4* | ||||||
| X-linked panhypopituitarism | SOX3* | Sox3 | Alliance of Genome Resources | ||||
Excel File
|
Transgenes and other genome features developed in mice to model this disease.
|
|||
| Disease Term | Transgenes and Other Genome Features | Mouse Models | |
| acromegaly | Tg(Mt1-GH1)#Jjk | 1 model | |
| ACTH-secreting pituitary adenoma | Tg(PyLT)1Vb | 1 model | |
| dermoid cyst of ovary | Tg(Amh-SMAD2*)#Jebu | 1 model | |
| insulinoma | Tg(RIP1-Tag)2Dh | 1 model | |
| ovarian cancer | Tg(Amhr2-SV40TAg)1Dcco | 1 model | |
| ovarian cancer | Tg(CAG-lacZ,-SV40)#Bcv | 1 model | |
| pancreatic carcinoma | Tg(Ela1-Myc)160Bri | 1 model | |
| pancreatic carcinoma | Tg(Ela1-Myc)159Bri | 1 model | |
| pancreatic carcinoma | Tg(Ela1-Myc)158Bri | 1 model | |
| pancreatic carcinoma | Tg(Cela1-luc,Cela1-TAg)#Nzh | 1 model | |
| pancreatic carcinoma | Tg(RIR-Tag)87Dh | 1 model | |
| pancreatic carcinoma | Tg(tetO-MYC)36Bop | 1 model | |
| pancreatic carcinoma | Tg(Ela1-TAg)18Bri | 1 model | |
| pancreatic carcinoma | Tg(Ela1-TAg)19Bri | 1 model | |
| pancreatic carcinoma | Tg(Ins2-Tag*,-flpe)#Gne | 2 models | |
| pancreatic carcinoma | Tg(RIP1-Tag)2Dh | 3 models | |
| polycystic ovary syndrome | Tg(Cyp17a1-NGF)2456Oje | 1 model | |
| primary hyperaldosteronism | Tg(Crh)227.1Pbl | 1 model | |
| primary hyperparathyroidism | Tg(PTH-CCND1)PC2Anar | 1 model | |
| primary pigmented nodular adrenocortical disease | Tg(tetO-Prkar1a*x2as)1Stra | 1 model | |
| prolactinoma | Tg(Prl-EGFR)#Sme | 1 model | |
| thyroid cancer | Tg(TG-TPR/NTRK1)#Rstn | 1 model | |
| thyroid gland follicular carcinoma | Tg(TG-NRAS*Q61K)#Msnt | 1 model | |
| thyroid gland papillary carcinoma | Tg(TG-BRAF*V600E)2Jaf | 1 model | |
| thyroid gland papillary carcinoma | Tg(tetO-BRAF*V600E)26Jaf | 1 model | |
| thyroid gland papillary carcinoma | Tg(TG-RET/CCDC6)42Cled | 1 model | |
| thyroid gland papillary carcinoma | Tg(TG-RET/NCOA4)3209Rstn | 1 model | |
| thyroid gland papillary carcinoma | Tg(TG-TPR/NTRK1)5215Rstn | 1 model | |
| thyroid hormone resistance syndrome | Tg(ACTB-THRB*)DSyc | 1 model | |
| type 1 diabetes mellitus | H2-I | 1 model | |
| type 1 diabetes mellitus | Tcra | 13 models | |
| type 1 diabetes mellitus | Tg(Cryaa-TAg,Ins2-CALM1)26Ove | 2 models | |
| type 1 diabetes mellitus | Tg(H2-Ea-G6pc2)69Tkay | 1 model | |
| type 1 diabetes mellitus | Tg(H2-Ea-Ins2)1Wehi | 1 model | |
| type 1 diabetes mellitus | Tg(H2-Ead)12Lt | 1 model | |
| type 1 diabetes mellitus | Tg(HLA-A/H2-D/B2M)1Dvs | 2 models | |
| type 1 diabetes mellitus | Tg(Igh-6/Igh-V281)3Jwt | 2 models | |
| type 1 diabetes mellitus | Tg(Igh-VB1-8/Igh-6m)1Mjsk | 1 model | |
| type 1 diabetes mellitus | Tg(IghelMD4)4Ccg | 1 model | |
| type 1 diabetes mellitus | Tg(Ins1-Cat,Tyr)25Pne | 2 models | |
| type 1 diabetes mellitus | Tg(Ins2*Y16A)3Ell | 1 model | |
| type 1 diabetes mellitus | Tg(Ins2-CD80)3B7Flv | 4 models | |
| type 1 diabetes mellitus | Tg(Ins2-Fasl)24Ach | 3 models | |
| type 1 diabetes mellitus | Tg(Ins2-GP)34-20Olds | 2 models | |
| type 1 diabetes mellitus | Tg(Ins2-HBEGF)5Rin | 1 model | |
| type 1 diabetes mellitus | Tg(Ins2-Nos2)31Okam | 1 model | |
| type 1 diabetes mellitus | Tg(Ins2-Nos2)40Okam | 4 models | |
| type 1 diabetes mellitus | Tg(Ins2-NP)25-3Olds | 2 models | |
| type 1 diabetes mellitus | Tg(INS-MT2A,Tyr)1Pne | 2 models | |
| type 1 diabetes mellitus | Tg(INS-SOD2)3Pne | 1 model | |
| type 1 diabetes mellitus | Tg(TcraAI4)1Dvs | 5 models | |
| type 1 diabetes mellitus | Tg(TcraTcrbNY8.3)1Pesa | 1 model | |
| type 1 diabetes mellitus 2 | Tg(Ins-Igf2)1Fbos | 3 models | |